Login / Signup

H. Pylori Treatment in the COVID-19 Era. What Have We Learned So Far?

Konstantinos EkmektzoglouTheodore Rokkas
Published in: Current gastroenterology reports (2024)
COVID-19 has produced more questions than answers as to the outcome of COVID-19 in H. Pylori infected patients, post-COVID-19 patients treated for H. pylori, acid suppression and COVID-19 incidence and outcomes, and H. pylori eradication treatment in patients having recovered from COVID-19. We strongly believe that this scientific uncertainty produced by the COVID-19 pandemic has set up the stage for an incremental change in H. pylori treatment as COVID-19 has offered us the chance to speed up how we will, in the near future, approach patients with a possible Η. pylori infection.
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus
  • type diabetes
  • metabolic syndrome
  • risk factors
  • insulin resistance
  • skeletal muscle
  • combination therapy
  • weight loss
  • glycemic control